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ABBREVIATIONS
FSS Fatigue Severity Scale
SDR Selective dorsal rhizotomy
SRFM Self-Reported Functional
Measure
AIM Selective dorsal rhizotomy (SDR) is a surgical treatment for spasticity in children with
cerebral palsy (CP). Studies suggest long-lasting effects of SDR on spasticity; long-term
effects on symptoms and function are not clear. This study tested whether adults with CP
(average 22y after SDR) report less pain, fatigue, and functional decline than a retrospectively
assessed non-surgical comparison group.
METHOD This was a case–control study. Eighty-eight adults with CP (mean age 27y; SDR=38
male/female/missing=20/16/2; non-surgical [comparison]=50, male/female=19/31) recruited
from a tertiary care center and the community completed a battery of self-reported outcome
measures. Regression models were used to test whether SDR status predicted pain, fatigue,
functional change, and hours of assistance (controlling for Gross Motor Function
Classification System level).
RESULTS SDR status did not significantly predict pain interference (p=0.965), pain intensity
(p=0.512), or fatigue (p=0.404). SDR related to lower decline in gross motor functioning
(p=0.010) and approximately 6 fewer hours of daily assistance than for those in the
comparison group (p=0.001).
INTERPRETATION Adults with CP who had SDR in childhood reported less gross motor
decline and fewer daily assistance needs than non-surgically treated peers, suggesting the
functional impact of SDR persists long after surgery.
Cerebral palsy (CP) remains common in the USA, affecting
as many as 3.1 in every 1000 children, and more children
with CP are surviving to adulthood.1,2 As children with CP
grow older, families may choose from a variety of options
for managing spasticity and other symptoms that contribute
to functional impairment. Of these options, selective dorsal
rhizotomy (SDR) is among the most invasive. This neuro-
surgical procedure, which is often performed in the first dec-
ade of life, involves selective severing of lumbosacral sensory
rootlets using electromyography guidance, with the goal of
decreasing spasticity and improving motor function. After
the procedure, the children participate in a rigorous pro-
gram of physical and occupational therapy lasting several
months, although protocols for postoperative rehabilitation
vary between institutions. They may undergo further treat-
ments such as oral medications, injected botulinum neuro-
toxin and phenol injections, and orthopedic surgery.3
Despite the variety of treatment options available to people
with CP, functional declines with aging, particularly in gross
motor function and gait, have been observed4–7 as early as
adolescence or early adulthood.8 Currently, there are still
limited data examining long-term outcomes of SDR, espe-
cially as these children reach adulthood.
Previous prospective studies in a single, small sample of
people who have undergone SDR have demonstrated reduc-
tions in spasticity, pain intensity, and pain interference that
are maintained even years after SDR.9,10 Although previous
studies have demonstrated short- and long-term benefits of
SDR in terms of reduced spasticity, prospective studies have
differed over the benefit in functional outcomes.10–12 Fur-
thermore, other than one study of 18 people that showed
that SDR was related to relatively low pain and pain inter-
ference,10 we lack understanding of how SDR affects symp-
tom experience as individuals age. This is important given
that symptoms such as pain and fatigue are highly prevalent
in adults with CP and have a detrimental effect on quality of
life and functional ability.3,13–15
To address these limitations in our understanding of how
SDR relates to symptoms and function in adulthood, in this
case–control study we compared adults with CP who either
did or did not undergo SDR as children in terms of self-
reported pain (intensity and location of pain), pain interfer-
ence, fatigue severity, and perceptions of change with aging
in motor function and required daily assistance. We hypoth-
esized that pain intensity, pain interference, prevalence of
back and lower extremity pain, and fatigue severity would
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be lower in the SDR group than the comparison (non-surgi-
cal) group owing to reduced spasticity, improved biome-
chanics, and decreased energy expenditure with motor
activities. Further, we hypothesized that SDR might delay
gross motor decline through lasting effects on spasticity and
thus contractures and other associated complications; we
expected that those who underwent SDR compared with
those who did not would require less daily assistance as a
result of better gross motor functioning. We included a self-
report functional measure to allow comparison of current
function and assistance needs within Gross Motor Function
Classification System (GMFCS) categories.
METHOD
Participant recruitment
In this case–control study, we recruited adults with CP who
had and had not undergone SDR in childhood. Selection for
the surgery was not included in the study activities; partici-
pants were assigned to each group on the basis of retrospec-
tive self-report of their rhizotomy status. Local institutional
review board approval was obtained before initiation of
study activities. Participants were asked to complete an
online self-reported survey battery and received US$15.00
for participation. A convenience sample was recruited from
a tertiary care center (University of Michigan Hospital and
Health Systems) and from the general community between
January 2014 and May 2015. Recruitment methods included
postal mail letters with the survey web address, face-to-face
contact in an adult CP clinic, an institutional research
recruitment website, and coordination with outside organi-
zations such as United Cerebral Palsy. Informed consent
was received through the initial survey access screen. Partic-
ipants were allowed to complete the survey at their own
pace in a location of their choosing. Those who wished to
participate during their clinic visit were provided with an
Apple iPad and a private location to use while completing
the survey. Volunteers were eligible to participate if they
had a diagnosis of CP, were between 18 years and 35 years
old, and had sufficient English fluency and cognitive ability
to respond independently to survey questions. Volunteers
were ineligible if they underwent SDR at age 10 years or
older or had any history of other spinal cord surgery. Only
those whose SDR was performed before age 10 were
included, to avoid confounding effects of age at time of sur-
gery since older age at SDR has been linked to worse func-
tional outcomes.16,17
Study procedures
Participants were asked to formulate their own response to
each question, and were allowed to miss any question that
they did not understand or feel comfortable answering.
Participants could use a physical aide or another person to
select each response if needed, as we anticipated that many
of the potential participants would have physical barriers
to completing the survey. Participants were not asked to
report need for physical assistance with completing the
survey.
Study measures
The survey included demographic information and infor-
mation about motor function, communication abilities,
medical treatments (including whether participants had
ever had a baclofen pump, tendon lengthening surgery, or
hip surgery), life satisfaction, health perception, and self-
reported inputs of body mass index (self-reported weight
and height). Demographic information included sex, living
situation, educational level, and employment or school
enrollment status. Current mobility was assessed using the
self-report version of the GMFCS,18 which assigns a level
ranging from I to V, from higher to lower independent
mobility. It has been shown to be a valid self-report mea-
sure of mobility. Current fine motor functioning was
assessed using the Manual Ability Classification System
(MACS)19 and current communication ability was assessed
using the Communication Function Classification System
(CFCS).20 Similar to the GMFCS, both measures assign a
level on an ordinal scale of I to V, ranging from better to
worse functioning.
Pain outcomes were measured using the Patient
Reported Outcome Measurement Information System
(PROMIS) Pain Intensity – Short Form 3a and Pain
Interference – Short Form 8a.21 PROMIS measures have
previously not been widely used in CP research; however,
these measures are widely accessible and address a multi-
tude of relevant participant reported outcomes. The
PROMIS Pain Intensity – Short Form asked respondents
to rate their worst and average pain in the previous
7 days as well as current pain. Items were rated on a 1 to
5 Likert scale and responses were summed for a possible
total score of 3 to 15, with higher scores indicating
higher pain intensity. The PROMIS Pain Interference –
Short Form asked respondents to rate how much pain
interfered with daily activities, housework, chores, partici-
pation in and enjoyment of social activities, enjoyment of
life, recreation, and family life. Items were rated on a 1
to 5 Likert scale and responses were summed for a possi-
ble total score of 8 to 40, with higher scores indicating
higher pain interference. Pain location was identified by
multiple-choice options indicating various body areas:
head, neck/upper back, lower back, upper extremities,
lower extremities, chest/abdomen. Participants were asked
to select all of the areas where they typically experienced
pain. Fatigue was assessed using the Fatigue Severity
Scale (FSS). The FSS has been used in many different
patient populations, including adults with CP,13 and has
been shown to be internally consistent, reliable, sensitive,
and valid in multiple patient populations.22
What this paper adds
• After selective dorsal rhizotomy, adults report decreased motor decline and
need for care, controlling for Gross Motor Function Classification System
level.
• They also reported higher function.
• They have similar prevalence of pain and fatigue as peers.
• Pain and fatigue are prevalent in both groups, emphasizing the need to
address other causes of these complaints in addition to spasticity.
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Perceived change in functional status was assessed in a
method similar to that of Opheim et al.5 Participants were
asked to grade both their overall motor function and walk-
ing ability (if applicable) as having improved, stayed the
same, or worsened with time. For those who noted wors-
ening, they were asked to estimate when they began to
notice that change in 5 year intervals (Appendix S1). The
Self-Reported Functional Measure (SRFM)23 was used as a
secondary outcomes measure. The SRFM contains 13
questions about activities of daily living, for which the par-
ticipant is asked to rate the amount of assistance they
require on a 4-point scale, ranging from ‘no extra time or
help’ to ‘total help or never do’. Possible scores for this
measure ranged from 13 to 52. Additionally, the SRFM
includes an item to report the number of hours of assis-
tance (0–24; paid or unpaid) that they receive each day.
Although this measure was developed for use in research
into spinal cord injury, it contains questions about func-
tional activities also relevant to people with CP.
Data analysis
Data analysis was performed using SPSS version 22 (IBM
SPSS Statistics, IBM Inc., NY, USA). Descriptive statistics
for all outcome variables were calculated and analyzed for
normality. Student’s t-tests and v2 tests were used to
examine group differences in demographic and clinical
(e.g. GMFCS) variables. The primary research questions
were examined using regression models. Linear regression
was used to test whether SDR status predicted pain inten-
sity, pain interference, and fatigue and functional (SRFM)
scores. Multinomial linear regression was used to test
whether SDR status predicted change in motor function
(worse, no change, better). In some cases, mean results are
presented to aid in interpreting findings. The fatigue mea-
sure (FSS) showed acceptable skew (0.12) and kurtosis
(1.18) values, but a slightly bimodal distribution; thus, a
non-parametric test of group differences in fatigue (i.e. the
Mann–Whitney U-test) was conducted to confirm/contrast
with the parametric tests results. All regression analyses
controlled for GMFCS level.
RESULTS
Eighty-eight adults with CP participated in this study. Char-
acteristics of participants are described in Table I. Most of
the control group was female (n=31; male n=19) whereas
most of the SDR group was male (n=20; female n=16; miss-
ing=2). The groups were not significantly different in age
(t[86]=0.46, p=0.646), sex (v2[1,86]=2.60, p=0.128), education
level (v2[1,85]=3.45, p=0.631), baclofen pump use
(v2[1,85]=0.364, p=0.546), hip surgery (v
2
[1,85]=1.862,
Table I: Characteristics of participants
Parameter Case Comparison Total p
n 38 50 88
Mean age, y:mo (SD) 27:4 (4:6) 26:10 (5:1) 27:0 (4:10) 0.646
Time since SDR, y:mo (range) 22:0 (11:7–28:4) N/A
Sex, n % male 20/55.6% 19/38.0% 45.3 0.128
Ever had baclofen pump, yes, n (% of group) 5/35 (14.3) 5/50 (10) 11.8 0.546
Ever had hip surgery, yes, n (% of group) 14/35 (40) 13/50 (26) 31.8 0.172
Ever had tendon lengthening surgery, yes, n (% of group) 19/35 (54) 32/50 (64) 60 0.368
Education level, n (% of group)
Less than high school diploma 2 (5.7) 5 (10.0) 7 (8.2) 0.631
High school diploma or GED 13 (37.1) 25 (50.0) 38 (44.7)
Vocational school/associates degree 8 (22.9) 8 (16.0) 16 (18.2)
Bachelor’s degree 9 (25.7) 7 (14.0) 16 (18.2)
Master’s degree 2 (5.7) 4 (8.0) 6 (7.1)
Doctorate 1 (2.9) 1 (2.0) 2 (2.3)
GMFCS level, n (% of group)
I 2 (5.3) 13 (26.0) 15 (17.0) 0.001
II 7 (18.4) 18 (36.0) 25 (28.4)
III 11 (28.9) 4 (8.0) 15 (17.0)
IV 14 (36.8) 7 (14.0) 21 (23.9)
V 4 (10.5) 8 (16.0) 12 (13.6)
CFCS level, n (% of group)
I 28 (75.7) 25 (51.0) 53 (61.6) 0.147
II 4 (10.8) 13 (26.5) 17 (19.8)
III 4 (10.8) 6 (12.2) 10 (11.6)
IV 1 (2.7) 3 (6.1) 4 (4.7)
V 0 (0.0) 2 (4.1) 2 (2.3)
MACS level, n (% of group)
I 13 (34.2) 16 (32.0) 29 (33.0) 0.975
II 14 (36.8) 20 (40.0) 34 (38.6)
III 6 (15.8) 7 (14.0) 13 (14.8)
IV 3 (6.0) 3 (6.0) 6 (6.8)
V 2 (5.3) 4 (8.0) 6 (6.8)
SDR, selective dorsal rhizotomy; N/A, not applicable; GED, general education development; GMFCS, Gross Motor Function Classification
System; CFCS, Communication Function Classification System; MACS, Manual Ability Classification System. Two participants in the case
group did not report their sex.
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p=0.172), tendon lengthening surgery (v2[1,85]=0.810,
p=0.368), CFCS level (v2[1,86]=6.79, p=0.147), or MACS
levels (v2[1,88]=0.49, p=0.975). There was a significant differ-
ence in GMFCS levels between the two groups
(v2[4,88]=18.55, p=0.001), with the non-surgical (comparison)
group having less motor involvement than the SDR group.
The SDR group primarily comprised individuals who had
undergone surgery at the University of Michigan Hospital
and Health Systems between 1988 and 2002; 29 of the 38
surgeries were performed at University of Michigan Hospi-
tal and Health Systems.
Pain intensity, interference, and location
In total, 65.9 per cent of participants had experienced some
level of pain on average in the previous 7 days. Pain inci-
dence was not significantly different between the case and
comparison groups, at 65.8 per cent and 66.0 per cent
respectively (v2[1,88]=0.00, p=0.984). SDR status was not
significantly associated with pain intensity (b[83]=0.07,
t=0.66, p=0.512) or pain interference (b[83]=0.01, t=0.04,
p=0.965). Pain location was also not significantly different
between the two groups. Low back and lower extremities
were the most commonly reported areas of pain for both
groups, with no statistically significant difference between
the two groups. Forty-two per cent of participants
endorsed low back pain (i.e. 34.2% of cases and 48.0% of
the comparison group; p=0.194). Over half (54.5%) of par-
ticipants reported pain in their lower extremities (i.e.
52.6% [20 out of 38] of the SDR group and 56.0% [28
out of 50] of the comparison group; p=0.753).
Fatigue
SDR status was not significantly related to fatigue scores
(b=0.09; t=0.79; p=0.404); non-parametric test results
were similarly non-significant (U=796.50, p=0.582). Aver-
age FSS score for all participants was 3.9 (standard devia-
tion [SD] 1.72). In the SDR group (n=35), the mean was
3.77 (SD 1.80). In the comparison group (n=49), the mean
was 4.00 (SD 1.68). A mean FSS score of four or higher
represents clinically significant fatigue.
Functional change
As depicted in Figure 1, in the SDR group, a larger pro-
portion reported improvement in overall motor function-
ing and a smaller proportion reported motor decline than
the non-surgical (comparison) group (v2[2,86]=9.131,
p=0.010). This finding was statistically significant even
when accounting for GMFCS in multinomial logistic
regression analysis (Wald test=10.21, p=0.001). However,
when the 66 participants who reported being ambulatory
at some point in their lives were asked about changes in
walking ability specifically, there was no significant differ-
ence between the two groups (v2[2,66]=1.625, p=0.444). For
those who reported declines in motor functioning, changes
were first noted between 1 year and 5 years of age for
three (13.6%), between 11 years and 15 years for two
(9.1%), between 16 years and 20 years for four (18.2%),
between 21 years and 25 years for eight (36.4%), between
26 years and 30 years for four (18.2%), and between 31
years and 35 years for one (4.5%); notably, the age at
which motor decline was first noted did not differ by SDR
status (v2[1,22]=1.553, p=0.907).
SRFM scores were also significantly different between
the two groups, with the SDR group reporting higher
scores (better function) when corrected for GMFCS. SDR
status contributed to 5.6 per cent of variance in SRFM
scores, with the SDR group achieving higher functional
scores when controlling for GMFCS (b=0.24; t=3.04,
p=0.003). As can be seen in Figure 2, SRFM scores were
higher for the SDR group in all GMFCS levels except V.
Results also showed that the SDR group reported signif-
icantly fewer total numbers of hours of help (paid or
unpaid) each day (b=0.36, t=3.41, p=0.001) in regres-
sion models that controlled for GMFCS; these analyses
indicate that the SDR group reported receiving 5.88 fewer
hours of help per day than the comparison group. As can
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Figure 1: Percent of participants in each group who reported better, unchanged, or worse overall motor functioning with time. [Colour figure can be
viewed at wileyonlinelibrary.com].
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be seen in Figure 3, the number of hours of help per day
was comparatively lower for the SDR group within each
GMFCS level (no data were provided by the two individu-
als with SDR in GMFCS level I).
DISCUSSION
To our knowledge, this is the first study to compare adults
with CP who underwent SDR as a child with those who
did not have the surgery in terms of a broad range of clini-
cally relevant outcomes, including pain intensity and inter-
ference, fatigue, changes in functional ability, and amount
of daily assistance used. Notably, there were no significant
differences in pain or fatigue outcomes between the SDR
and the non-surgical comparison groups. While these data
do not suggest a benefit of SDR in terms of pain and fati-
gue, they do suggest that SDR does not have a deleterious
effect in terms of these symptoms as the children age and
reach adulthood. Although previous research has shown
that pain and fatigue are common in adults with CP, pain
intensity, pain interference, and fatigue (FSS) scores were
quite low in our study population, although in the same
range as other long-term SDR studies.5,10,24
Research on outcomes for SDR has demonstrated good
evidence for lasting reduction in spasticity and improved
gait mechanics, with less support for significant improve-
ment in function and participation.25 However, in the face
of well-documented, multifactorial functional decline in
adults with CP,4–8 it is pertinent to investigate whether
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Figure 2: Mean Self-Reported Functional Measure (SRFM) scores for the selective dorsal rhizotomy (SDR) and non-surgical (comparison) groups within
each Gross Motor Function Classification (GMFCS) level. [Colour figure can be viewed at wileyonlinelibrary.com].
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childhood interventions have an effect on the rate of
decline. For example, Tedroff et al.10 reported the best
improvement in Gross Motor Function Measure scores
3 years after rhizotomy, followed by decline. Most of the
decline that occurred was in participants who started with
greater motoric impairment, whereas individuals in
GMFCS levels I or II gained and plateaued in motor func-
tion. Ailon et al.11 followed 44 patients an average of
14 years 5 months after SDR, and found small improve-
ments in motor function scores at long-term follow-up for
those in GMFCS levels II or III, but not for those in
GMFCS levels IV or V. These results must be considered
within the context of expected functional trajectories for
people with CP, and therefore may not represent improve-
ment related to the surgery. Functional plateau and decline
with age is expected in CP, and evidence suggests espe-
cially precipitous declines among those with greater motor
involvement. For example, Opheim et al.5 found that indi-
viduals with bilateral involvement had deterioration of
walking skills much sooner than those with unilateral
involvement. We should ask, then, whether intervention
affects the rate of this process across functional levels. In
our study, adults who had SDR in childhood were less
likely to self-report general motor decline, a finding that
was supported by higher SRFM scores, and less reliance
on daily assistance from others. Importantly, these findings
held true even when controlling for GMFCS level. Inter-
estingly, this result was not replicated for changes in walk-
ing function, perhaps because of the fewer participants for
whom this question was applicable; only 25 participants in
the SDR group and 41 in the comparison group reported
ever walking, which suggests these analyses may be under-
powered. Alternatively, it may suggest that our study popu-
lation took a more global view of motor function, rather
than focusing on walking alone.
Study strengths and limitations
Although we had a relatively modest sample size, this study
compares well with other long-term SDR studies. We
included an age-matched comparison group, which allowed
interpretation of findings in the context of a similarly aged
population with CP. Further, the study only included
adults, leading to a longer follow-up time than many of
the currently published SDR studies. The sole use of self-
reported outcome measures in this study conveys both
benefits and limitations; many health-related quality of life
outcomes, especially those that are not easily observable
(e.g. pain, fatigue), are best measured by self-report. How-
ever, a retrospective self-report of changes in function is
likely to be less reliable than prospective measurement. A
combination of self-reported measures, proxy-reported
measures, and objective measures of functioning is recom-
mended for future studies as a means of optimizing data
reliability and validity. Responses to the question about the
hours of unpaid and paid help received each day suggest
that interpretation of the question may have differed some-
what across respondents; for instance, some individuals in
GMFCS level I answered that they received 24 hours of
care, whereas one person in GMFCS level IV answered
that they received only 1 hour of care, suggesting that
interpretation of ‘help’ may vary. Nonetheless, we have no
reason to expect that differences in interpretation were sys-
tematically different across the SDR and comparison
groups; in other words, any response bias is not expected
to affect the group differences that were found. Future
research should assess help or assistance further, with more
specific questions and/or adjunctive reports from parents,
caregivers, spouses, etc.
The SDR and comparison groups were significantly
different in terms of GMFCS levels; however, we were
able to control for this difference in multivariate statisti-
cal tests. The two groups were also likely to be different
in terms of types of CP, since we included participants
who reported any diagnosis of it. The SDR group prob-
ably primarily comprised participants with spastic diple-
gic or quadriplegic CP, whereas those in the comparison
group might have been more likely to include other
types of CP (dystonic, athetoid, hemiplegic, etc.). There-
fore, this study has included a more global view of
functional status via GMFCS, acknowledging that partici-
pants may not be able to accurately self-report the sub-
type of their CP diagnosis. Additionally, the SRFM,
developed for use in participants with spinal cord injury,
may be less valid in the CP population. Original ques-
tions included in the study may have been difficult for
participants to interpret in the way the researchers
intended; however, this potential for bias was present in
both study groups.
Recruiting in clinics and collecting data via the Internet
raises the potential of selecting participants who have regu-
lar medical follow-up and higher socioeconomic status.
We also included only a few participants who had their
SDR elsewhere than at the University of Michigan. This
makes it more difficult to generalize these results to other
medical centers that perform SDR, especially as selection
criteria may vary between institutions. The high propor-
tion of participants in the SDR group in GMFCS level IV
probably reflects older selection criteria at the University
of Michigan Hospital and Health Systems, as SDR is now
more likely to be recommended in ambulatory patients.
However, despite the greater motor impairment of those
in the SDR group, they reported requiring less care than
their GMFCS-matched peers.
Conclusion
Adults with CP who underwent SDR as children reported
similar prevalence and impact of pain and fatigue as adults
with CP who did not have the surgery. They reported
higher levels of function, had fewer complaints of gross
motor decline, and needed less assistance than their peers
in the non-surgical group. More research is required to
understand the nature of functional decline in adults with
CP, and the impact of pediatric interventions. In addition,
the lack of significant difference in pain prevalence, pain
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interference, and fatigue suggests that this particular spas-
ticity treatment does not have a significant impact on these
common symptoms, and more investigation is required to
determine best practices to decrease pain and fatigue in
adults with CP.
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